This Viewpoint discusses the uncertain evidence for second-line treatment of pleural malignant mesothelioma.
This genomic analysis compares the prevalence and types of mutations in a cohort of black and white patients with lung cancer.
This cross-sectional study of the NHANES 2013-2014 estimates the prevalence of genital human papillomavirus (HPV) infection and the HPV vaccination rate in the United States among adult men and examines potential risk factors for HPV infection.
This phase 2, single-arm clinical trial examines the safety and objective response rate of topical imiquimod in combination with systemic chemotherapy for treatment of breast cancer cutaneous metastases.
This cohort study determines the frequency of thyroid carcinoma in Brazilians with Li Fraumeni syndrome who are carriers of a founder TP53 p.R337H mutation.
A pregnant woman in her 20s presented with abdominal pain and a cystic mass that appeared on scanning results to originate from the body of the pancreas. What is your diagnosis?
This subgroup analysis of a randomized clinical trial of radiation therapy vs radiation therapy plus androgen deprivation therapy for prostate cancer compares the performance of 4 candidate surrogates for all-cause mortality in men with localized unfavorable-risk prostate cancer using the proportion of treatment-effect metric.
This secondary analysis of a randomized clinical trial assesses whether molecular variables improve prognostic classification of glioblastomas treated with radiation and temozolomide.
This review examines recent developments in tumor visualization for locally advanced, recurrent, and metastatic prostate cancer.
This Viewpoint asserts that there is limited benefit for whole-brain radiation therapy in the treatment of brain metastases.
This Viewpoint asserts that whole-brain radiation therapy is beneficial for the treatment of brain metastases.
This study assesses differences in survival according to the time interval between non–small-cell lung cancer resection and the initiation of postoperative chemotherapy to determine the association between adjuvant treatment timing and efficacy.
This study compared survival outcomes among patients with newly diagnosed cT1-2 N1-2b human papillomavirus-negative oropharyngeal squamous cell carcinoma when treated with primary surgical resection vs chemoradiation.
This Special Communication provides consensus recommendations for a risk-adapted approach to treatment of Waldenström macroglobulinemia.